Urgent Referral for Unexplained Iron Deficiency Anaemia in Men Over 60

According to NICE guidelines, men over 60 with unexplained iron deficiency anaemia and a haemoglobin level of 120 g/L or less should be urgently referred to a lower gastrointestinal specialist for further assessment. In this case, the patient has been confirmed to have iron deficiency anaemia with a haemoglobin level below 120 g/L, despite being otherwise well with no other focal signs or symptoms, including gastrointestinal symptoms. Therefore, based solely on the unexplained nature and level of the iron deficiency anaemia, urgent referral is necessary.

Understanding Drug-Induced Thrombocytopenia

Drug-induced thrombocytopenia is a condition where a person’s platelet count drops due to the use of certain medications. This condition is believed to be immune-mediated, meaning that the body’s immune system mistakenly attacks and destroys platelets. Some of the drugs that have been associated with drug-induced thrombocytopenia include quinine, abciximab, NSAIDs, diuretics like furosemide, antibiotics such as penicillins, sulphonamides, and rifampicin, and anticonvulsants like carbamazepine and valproate. Heparin, a commonly used blood thinner, is also known to cause drug-induced thrombocytopenia. It is important to be aware of the potential side effects of medications and to consult with a healthcare provider if any concerning symptoms arise. Proper management and monitoring of drug-induced thrombocytopenia can help prevent serious complications.

The ANA test is commonly used to screen for autoimmune rheumatic diseases in adults, but it is not very accurate without typical clinical features. While tests like anti-dsDNA are more specific for SLE, they are less sensitive, meaning a negative result doesn’t necessarily rule out the condition.

Systemic lupus erythematosus (SLE) can be investigated through various tests, including antibody tests. ANA testing is highly sensitive and useful for ruling out SLE, but it has low specificity. About 99% of SLE patients are ANA positive. Rheumatoid factor testing is positive in 20% of SLE patients. Anti-dsDNA testing is highly specific (>99%) but less sensitive (70%). Anti-Smith testing is also highly specific (>99%) but has a lower sensitivity (30%). Other antibody tests that can be used include anti-U1 RNP, SS-A (anti-Ro), and SS-B (anti-La).

Monitoring of SLE can be done through various markers, including inflammatory markers such as ESR. During active disease, CRP levels may be normal, and a raised CRP may indicate an underlying infection. Complement levels (C3, C4) are low during active disease due to the formation of complexes that lead to the consumption of complement. Anti-dsDNA titres can also be used for disease monitoring, but it is important to note that they are not present in all SLE patients. Overall, these investigations can help diagnose and monitor SLE, allowing for appropriate management and treatment.

Diagnosis of Microcytic Anaemia in a Patient with Rheumatoid Arthritis

In a patient with rheumatoid arthritis presenting with microcytic anaemia, the possibility of anaemia of chronic disease should be considered. However, further tests should be done as a reversible or treatable factor may be found. B12 deficiency and haemolytic anaemia can be ruled out as they cause elevated MCV measurements. Microcytic anaemia should prompt consideration of iron deficiency, and thalassaemia trait should also be borne in mind if indicated clinically. Iron/TIBC measurement is the most likely test to diagnose microcytic anaemia due to iron deficiency. However, the normal ferritin should be interpreted with caution as it may be elevated due to underlying inflammation or infection. In this case, iron/total iron binding capacity may be more useful markers of iron deficiency. It is also worth mentioning that DMARDs such as methotrexate can cause anaemia, but this is typically macrocytic and not the case in this patient.

Hodgkin’s Disease: A Malignant Lymphoid Proliferation

Hodgkin’s disease is a type of cancer that affects the lymphoid system. It is characterized by the abnormal growth of cells in the lymph nodes, which can cause swelling and tenderness. In addition to lymphadenopathy, patients with Hodgkin’s disease may also experience general pruritus (itchiness) and night sweats. These symptoms can be caused by the release of chemicals from the cancerous cells, which can affect the body’s immune system and cause inflammation. Early diagnosis and treatment are important for managing Hodgkin’s disease and improving outcomes for patients.

If a patient is taking aminosalicylates, they may experience various haematological adverse effects, including agranulocytosis. Therefore, it is crucial to conduct a full blood count promptly if the patient presents with symptoms such as fever, sore throat, fatigue, or bleeding gums.

While C-reactive protein may be a part of the overall management plan, it is not the most critical initial investigation and is unlikely to alter the management plan.

Although the monospot test for glandular fever may be useful if glandular fever is suspected, it is not the primary investigation that needs to be conducted urgently.

Similarly, while a throat swab may be necessary as part of the overall management plan, it is not the most crucial initial investigation that needs to be performed urgently.

Aminosalicylate Drugs for Inflammatory Bowel Disease

Aminosalicylate drugs are commonly used to treat inflammatory bowel disease (IBD). These drugs work by releasing 5-aminosalicyclic acid (5-ASA) in the colon, which acts as an anti-inflammatory agent. The exact mechanism of action is not fully understood, but it is believed that 5-ASA may inhibit prostaglandin synthesis.

Sulphasalazine is a combination of sulphapyridine and 5-ASA. However, many of the side effects associated with this drug are due to the sulphapyridine component, such as rashes, oligospermia, headache, Heinz body anaemia, megaloblastic anaemia, and lung fibrosis. Mesalazine is a delayed release form of 5-ASA that avoids the sulphapyridine side effects seen in patients taking sulphasalazine. However, it is still associated with side effects such as gastrointestinal upset, headache, agranulocytosis, pancreatitis, and interstitial nephritis.

Olsalazine is another aminosalicylate drug that consists of two molecules of 5-ASA linked by a diazo bond, which is broken down by colonic bacteria. It is important to note that aminosalicylates are associated with a variety of haematological adverse effects, including agranulocytosis. Therefore, a full blood count is a key investigation in an unwell patient taking these drugs. Pancreatitis is also more common in patients taking mesalazine compared to sulfasalazine.

When it comes to diagnosing restless legs syndrome, there are several blood tests that could be considered. However, out of all of them, the most crucial one is the ferritin test. This is because a low level of ferritin in the blood is often the primary cause of secondary restless legs syndrome.

Restless Legs Syndrome: Symptoms, Causes, and Management

Restless legs syndrome (RLS) is a common condition that affects between 2-10% of the general population. It is characterized by spontaneous, continuous movements in the lower limbs, often accompanied by paraesthesia. Both males and females are equally affected, and a family history may be present. Symptoms typically occur at night but may progress to occur during the day, and are worse at rest. Movements during sleep may also be noted by a partner, known as periodic limb movements of sleep (PLMS).

There are several causes and associations with RLS, including a positive family history in 50% of patients with idiopathic RLS, iron deficiency anaemia, uraemia, diabetes mellitus, and pregnancy. Diagnosis is primarily clinical, although blood tests such as ferritin may be appropriate to exclude iron deficiency anaemia.

Management of RLS includes simple measures such as walking, stretching, and massaging affected limbs, as well as treating any underlying iron deficiency. Dopamine agonists such as Pramipexole and ropinirole are first-line treatments, while benzodiazepines and gabapentin may also be used. With proper management, individuals with RLS can experience relief from their symptoms and improve their quality of life.

Diagnostic Imaging for Unilateral Lymphadenopathy: Excision Biopsy as the Best Option

Unilateral lymphadenopathy without pain is most likely caused by lymphoma, either Hodgkin’s or non-Hodgkin’s. Tuberculosis is a less likely diagnosis but should not be ruled out, especially in patients with risk factors. Systemic symptoms (B symptoms) suggest Hodgkin’s disease. Excisional node biopsy is the best diagnostic option as it allows for the identification of lymphomas based on lymph node morphology. CT scans of the thorax and abdomen are used for staging Hodgkin’s lymphoma, while fine-needle aspiration biopsy is less helpful as it fails to reveal the lymph node architecture and may not retrieve Reed-Sternberg cells. MRI scans of the neck are not commonly used for lymphoma assessment, while ultrasonography is commonly used for thyroid lump detection and assessment.

Blood Donation Eligibility Criteria

To ensure the safety of blood transfusions, there are certain eligibility criteria that potential donors must meet. Here are some corrections to common misconceptions:

Travel to an endemic malaria area: Donors must wait six months after traveling to an endemic malaria area before donating blood. If they fell ill abroad or were resident for more than six months in Sub-Saharan Africa, they must wait even longer.

Age: Donors must be between 17 and 66 years old (up to 70 if they have given blood before). If they are over 70 years old, they need to have given blood in the last two years to continue donating.

Body piercing and tattoo: Donors are deferred if they have had body piercing or a tattoo in the previous four months.

Underweight: Donors should weigh at least 50 kg. For other contraindications, please refer to the provided link.

Immune-Mediated Thrombocytopenic Purpura in Children

This child is experiencing immune-mediated thrombocytopenic purpura, which is the most common cause of low platelets in children. It occurs due to immune-mediated platelet destruction and typically affects children between 2 and 10 years old, usually after a viral infection. Symptoms include purpura, bruising, nosebleeds, and mucosal bleeding. While intracranial hemorrhage is a rare complication, it can be serious. However, in most cases, ITP is self-limiting and acute.

While abnormal bruising can also be a symptom of acute lymphoblastic leukemia (ALL), the child’s history and clinical features are more consistent with ITP. ALL typically presents with malaise, recurrent infections, pallor, hepatosplenomegaly, and lymphadenopathy, none of which are present in this case.

Other conditions that can cause purpura include haemolytic uraemic syndrome, Henoch-Schönlein purpura, and meningococcal septicaemia. However, these conditions have distinct symptoms and presentations that differ from ITP.

In summary, immune-mediated thrombocytopenic purpura is a common cause of low platelets in children, typically occurring after a viral infection. While it can cause purpura and bruising, it is usually self-limiting and acute. Other conditions that can cause purpura have distinct symptoms and presentations that differ from ITP.